STE - STERIS plc
| Previous Close | 115.75 |
| Open | 115.31 |
| Bid | 96.18 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 112.32 - 115.31 |
| 52 Week Range | 82.88 - 121.67 |
| Volume | 483,325 |
| Avg. Volume | 351,569 |
| Market Cap | 9.521B |
| Beta (3Y Monthly) | 0.90 |
| PE Ratio (TTM) | 30.61 |
| EPS (TTM) | 3.68 |
| Earnings Date | Feb 5, 2019 - Feb 11, 2019 |
| Forward Dividend & Yield | 1.36 (1.15%) |
| Ex-Dividend Date | 2018-11-27 |
| 1y Target Est | 132.17 |
- Thomson Reuters StreetEvents•15 hours ago
Edited Transcript of STE earnings conference call or presentation 6-Nov-18 3:00pm GMT
Q2 2019 STERIS plc Earnings Call
- Simply Wall St.•12 days ago
Is STERIS plc’s (NYSE:STE) ROE Of 10% Impressive?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Read More...
- Zacks•12 days ago
Steris (STE) Hits Fresh High: Is There Still Room to Run?
Steris (STE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Markit•12 days agoSee what the IHS Markit Score report has to say about Steris PLC.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Zacks•13 days agoSTERIS (STE) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
STERIS (STE) continues to gain from strength in all business segments in Q2.
Motley Fool•15 days agoSteris Corp (STE) Q2 2019 Earnings Conference Call Transcript
STE earnings call for the period ending September 30, 2018.
- Zacks•15 days ago
Steris (STE) Q2 Earnings and Revenues Surpass Estimates
Steris (STE) delivered earnings and revenue surprises of 1.85% and 3.35%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•15 days ago
Steris: Fiscal 2Q Earnings Snapshot
On a per-share basis, the Derby, Britain-based company said it had profit of 91 cents. Earnings, adjusted for non-recurring costs, came to $1.10 per share. The results topped Wall Street expectations. ...
- GlobeNewswire•15 days ago
STERIS Announces Financial Results for Fiscal 2019 Second Quarter
DERBY, U.K. - (November 6, 2018) - STERIS plc (STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2019 second quarter ended September 30, 2018. Revenue as reported for the quarter increased 7% to $679.0 million compared with $634.2 million in the second quarter of fiscal 2018, with growth across all segments. Constant currency organic revenue (see Non-GAAP Financial Measures) growth was 9% for the second quarter of fiscal 2019.
- Zacks•19 days ago
Will Steris (STE) Beat Estimates Again in Its Next Earnings Report?
Steris (STE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Markit•19 days agoSee what the IHS Markit Score report has to say about Steris PLC.
Steris PLC NYSE:STE
- GlobeNewswire•29 days ago
STERIS to Participate in the Stephens NY Investment Conference
DERBY, U.K. - October 23, 2018 - STERIS plc (STE) ("STERIS" or the "Company") announced that it will participate in the Stephens NY Investment Conference on Wednesday, November 7, 2018. Michael J. Tokich, STERIS`s Senior Vice President and Chief Financial Officer, will present at 1:45 p.m. Eastern Time. A simultaneous webcast and replay of the Company`s presentation will be available on STERIS`s investor relations website at www.steris-ir.com. STERIS`s mission is to help our Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe.
- GlobeNewswire•29 days ago
STERIS to Announce Fiscal 2019 Second Quarter Financial Results on November 6, 2018
DERBY, U.K. - October 23, 2018- STERIS plc (STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2019 second quarter financial results at 10:00 a.m. Eastern Time on Tuesday, November 6, 2018. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. STERIS`s mission is to help our Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe. The referenced conference call and related release may contain statements concerning certain trends, expectations, forecasts, estimates, or other forward-looking information affecting or relating to STERIS or its industry, products or activities that are intended to qualify for the protections afforded "forward-looking statements" under the Private Securities Litigation Reform Act of 1995 and other laws and regulations.
- GlobeNewswire•last month
Report: Developing Opportunities within Balchem, STERIS plc, Tableau Software, Werner Enterprises, Wabco, and Weis Markets — Future Expectations, Projections Moving into 2018
NEW YORK, Oct. 22, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Kiplinger•last month
The “Accelerators”: 13 Dividend Stocks With Rapidly Growing Payouts
Dividend growth stocks are a time-honored tool for building wealth. Implementing a dividend growth strategy begins with identifying well-managed companies that have solid balance sheets and steadily rising earnings. After all, what company would hike dividends if they anticipated future earnings would decline? A major advantage of dividend growth investing is the likelihood of capturing some total return even if the share price stagnates. For instance, depending on the length of time held, dividends account for anywhere between 27% and 60% of the total return of the Standard & Poor's 500-stock index. Dividend growth investing also lets you leverage the exponential growth that comes from compounding of reinvested dividends, and it's a hedge against inflation, as rising payouts counter the effect of the dollar's shrinking purchasing power. Better still, dividend growth stocks also have been shown to outperform non-dividend payers and the overall market. While any dividend growth is better than no growth, the best scenario is a stock whose payout is actually accelerating; your yield on cost will rapidly rise, eventually overtaking and exceeding the yields of stocks with high but stagnant payouts. Here's a look at 13 "Dividend Accelerators": a group of well-known dividend stocks that have recently ramped up their payout growth. SEE ALSO: 16 High-Yielding Monthly Dividend Payers
Markit•last monthSee what the IHS Markit Score report has to say about Steris PLC.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Markit•last monthSee what the IHS Markit Score report has to say about Steris PLC.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- Simply Wall St.•2 months ago
Does STERIS plc (NYSE:STE) Look Attractive Based On These Two Valuation Methods?
With so many different financial models generating different conclusions, choosing the most relevant one to value a company can be daunting. A prime example of conflicts between valuation models is Read More...
- Zacks•2 months ago
STERIS (STE) Strategic Growth Strong Amid Several Headwinds
STERIS (STE) impresses with favorable underlying market trends apart from new products and service offerings. Yet, a severe competition lurking beneath is worrisome for the company.
- Zacks•2 months ago
Why Is Steris (STE) Down 1.2% Since Last Earnings Report?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Simply Wall St.•3 months ago
What You Must Know About STERIS plc’s (NYSE:STE) Financial Strength
Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as STERIS plc (NYSE:STE), with a market capitalization of US$9.73b, rarely draw their attention from the investing community.Read More...
- Zacks•3 months ago
STERIS (STE) Strategic Growth Strong, Competition a Woe
STERIS' (STE) beneficial underlying market trends along with new product and service offerings are impressive. Meanwhile, the company worries over facing a severe competition.
- Zacks•3 months ago
STERIS (STE) Q1 Earnings & Revenues Beat Estimates, Up Y/Y
STERIS (STE) continues to gain from strength in all business segments in Q1.
- Associated Press•3 months ago
Steris: Fiscal 1Q Earnings Snapshot
On a per-share basis, the Derby, Britain-based company said it had net income of 82 cents. Earnings, adjusted for non-recurring costs, came to $1 per share. The results surpassed Wall Street expectations. ...
- ACCESSWIRE•3 months ago
STERIS plc to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / STERIS plc (NYSE: STE ) will be discussing their earnings results in their Q1 Earnings Call to be held on August 8, 2018 at 10:00 AM Eastern Time. To listen ...
